Pharmacokinetics and Side Effects of Δ9-Tetrahydrocannabinol and Cannabidiol in Patients with Different Stages of CKD
Abstract Introduction: Chronic kidney disease (CKD) affects approximately 10% of the global population and is associated with a large symptom…
